Clostridium difficile infection.

@article{Leffler2015ClostridiumDI,
  title={Clostridium difficile infection.},
  author={Daniel A. Leffler and John Thomas Lamont},
  journal={The New England journal of medicine},
  year={2015},
  volume={372 16},
  pages={
          1539-48
        }
}
This article reviews the pathogenesis, epidemiology, diagnosis, and treatment of this nosocomial and potentially fatal infectious diarrhea, as well as the associated risk factors. New treatments include fecal microbiota transplantation for disease that is resistant to vancomycin. 
View on PubMed
med.upenn.edu
1,138 Citations
Highly Influential Citations
56
Background Citations
392
Methods Citations
12
Results Citations
10

Figures and Tables from this paper

1,138 Citations

Citation Type

Citation Type

The Challenge of Clostridium difficile Infection
TLDR
This commentary provides an update regarding the epidemiology, diagnosis, current recommended management, and challenges surrounding C. difficile infection.
Clostridium Difficile Infection—Diagnosis, Treatment and Prevention
TLDR
C. difficile is a leading cause of hospital associated gastrointestinal illness, placing high economic burden on the healthcare system and it frequently causes large hospital outbreaks.
Trends in Incidence and Clinical Outcomes of Clostridioides difficile Infection, Hong Kong
TLDR
Surveillance of C. difficile infections suggests correlation of incidence to antibiotic stewardship programs, and further research is needed to establish a cause-and-effect relationship.
Mechanisms of Colonization Resistance Against Clostridioides difficile.
TLDR
Commensal gut microbes are critical for providing colonization resistance against C. difficile, and can be leveraged as non-antibiotic alternative therapeutics for the prevention and treatment of CDI.
Community-acquired Clostridium difficile infection.
  • George P. Kim, N. Zhu
  • Medicine, Biology
    Canadian family physician Medecin de famille canadien
  • 2017
TLDR
The bacterium Clostridium difficile is transmitted by the fecal-oral route and can cause illness ranging from diarrhea to colitis, toxic megacolon, and death.
The outcomes of Clostridioides difficile infection in inpatient liver transplant population
TLDR
The aim is to determine the inpatient outcomes of liver transplant patients with Clostridioides difficile infection (CDI) and trends in the last few years.
Clostridium difficile and Antibiotic-associated Diarrhea
TLDR
Clostridium difficile and Antibiotic-associated Diarrhea and Indian J Crit Care Med 2020;24(Suppl 4):S162–S167.
"Allogenic Fecal Microbiota Transplantation in Clostridioides Difficile Infection: A Case Series in Mexico"
TLDR
Clostridioides difficile is a gram-positive, spore-forming bacterium that produces toxins that causes diarrhoea, fever, and rash in people and animals infected with the bacterium.
Clostridium difficile Infection.
TLDR
A brief synopsis of a few recent publications that focused on C difficile infections, including comments regarding the implications within pediatric infectious diseases.
Association Between Outpatient Antibiotic Prescribing Practices and Community-Associated Clostridium difficile Infection
A modest, 10% reduction in outpatient antibiotic prescribing among U.S. adults could result in a substantial 17% reduction in Clostridium difficile infections that originate in the community.
...
...

References

SHOWING 1-10 OF 153 REFERENCES
Clinical predictors of recurrent Clostridium difficile infection in out‐patients
TLDR
Clostridium difficile infection (CDI) recurs in 20–30% of patients and requires further investigation to determine the cause of recurrence.
Clostridium difficile colitis following treatment with metronidazole and vancomycin.
A 25 year old woman developed Clostridium difficile colitis following a course of vancomycin and metronidazole prescribed for pelvic inflammatory disease. The condition resolved after treatment with…
Treatment of Clostridium difficile-associated disease.
TLDR
The review discusses the different management strategies for initial and recurrent symptomatic C difficile infections.
THERAPEUTIC IMPLICATIONS OF CLOSTRIDIUM DIFFICILE TOXIN DURING RELAPSE OF CHRONIC INFLAMMATORY BOWEL DISEASE
Is Clostridium difficile-associated infection a potentially zoonotic and foodborne disease?
  • M. Rupnik
  • Biology, Medicine
    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
  • 2007
TLDR
Reports have shown a marked overlap between isolates from calves and humans, including two of the predominant outbreak types, 027 and 017, suggesting that food could be involved in the transmission of C. difficile from animals to humans.
Current Status of Clostridium difficile Infection Epidemiology
  • F. Lessa, C. Gould, L. McDonald
  • Medicine, Biology
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
  • 2012
TLDR
Current genetic analysis suggests that C. difficile has a highly fluid genome with multiple mechanisms to modify its content and functionality, which can make C.difficile adaptable to environmental changes and potentially lead to the emergence of more virulent strains.
Pathogenesis of Clostridium difficile-associated diarrhoea.
  • C. Pothoulakis
  • Medicine, Biology
    European journal of gastroenterology & hepatology
  • 1996
TLDR
Clostridium difficile is now regarded as a major enteric pathogen in hospitals and nursing-home facilities and an interplay between lamina propria neuroimmune cells and intestinal epithelial cells may be central in pathogenesis of this toxin-mediated inflammatory response.
Immune response to Clostridium difficile infection.
  • C. Kelly
  • Medicine, Biology
    European journal of gastroenterology & hepatology
  • 1996
TLDR
A number of clinical studies indicate that antitoxin responses in both serum and intestinal secretions may be protective whereas an inadequate immune response predisposes to severe or recurrent C. difficile diarrhoea.
CLOSTRIDIUM DIFFICILE ASSOCIATED DIARRHŒA: A ROLE IN INFLAMMATORY BOWEL DISEASE?
Fecal Microbiota Transplant for Treatment of Clostridium difficile Infection in Immunocompromised Patients
TLDR
This series demonstrates the effective use of FMT for CDI in IC patients with few SAEs or related AEs, and there were no related infectious complications in these high-risk patients.
...
...